Skip to main content
Equibles

NATIXIS ADVISORS, LLC

Position in GMAB — Genmab A/S

CIK 1018331 Boston, MA
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,720,501
-$183,892 QoQ
Shares Held
62,632
-11.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIXIS ADVISORS, LLC holds $495,549,179 across 38 Biotechnology names. GMAB ranks #25 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 448,631 $222,848,476
2 REGN
Regeneron Pharmaceuticals, Inc.
 129,236 $80,583,815
3 TECH
BIO-TECHNE Corp
 818,905 $57,855,638
4 ALNY
Alnylam Pharmaceuticals, Inc.
 75,311 $22,670,870
5 ARGX
Argenx SE
 19,088 $17,709,273
6 INSM
INSMED Inc
 73,607 $7,847,978
7 HALO
Halozyme Therapeutics, Inc.
 97,536 $7,634,142
8 JAZZ
Jazz Pharmaceuticals plc
 29,928 $7,211,749

All Filings in GMAB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,720,501 62,632
2026-03-31 $1,904,393 70,980
2025-12-31 $2,560,126 83,121
2025-09-30 $5,948,415 193,949
2025-06-30 $2,694,992 130,445
2025-03-31 $2,516,518 128,525
2024-12-31 $4,294,398 205,769
2024-09-30 $5,036,005 206,563
2024-06-30 $3,998,835 159,126
2024-03-31 $7,057,981 235,974
2023-12-31 $5,979,487 187,798
2023-09-30 $8,073,197 228,897
2023-06-30 $6,264,504 164,812
2023-03-31 $6,698,510 177,397
2022-12-31 $8,489,010 200,307
2022-09-30 $7,621,685 237,214
2022-06-30 $4,162,326 128,111
2022-03-31 $5,552,978 153,482
2021-12-31 $5,723,224 144,672
2021-09-30 $6,325,006 144,737
2021-06-30 $6,529,043 159,908
2021-03-31 $4,130,440 125,813
2020-12-31 $5,477,023 134,703
2020-09-30 $4,854,595 132,603
2020-06-30 $5,377,563 158,677
2020-03-31 $7,171,882 338,456